# Proline-Mediated Inhibition of ATPIF1-mTOR Signaling Alleviates Radiation-Induced Macrophage Polarization and Colon Inflammation

**Authors:** Lei Chang, Le Zhou, Shan Jiang, Kai Wei, Jie Li, Junhong Zhao, Kavita Shah, Xinzhou Deng, Renhuang Sun, Xiaoyu Zuo, Zhenzhen Wang, Liting Ding, Zhiguo Luo, Lihua Duan, Yutao Yan

PMC · DOI: 10.1007/s10753-025-02404-3 · Inflammation · 2026-02-25

## TL;DR

Proline reduces radiation-induced inflammation by inhibiting a key signaling pathway in macrophages.

## Contribution

This study identifies proline as a novel inhibitor of radiation-induced M1 macrophage polarization via the ATPIF1-mTOR axis.

## Key findings

- Radiation increases M1 macrophage polarization and pro-inflammatory cytokines.
- Proline supplementation reverses radiation-induced mitochondrial dysfunction and inflammation.
- The ATPIF1-mTOR axis is central to radiation-induced inflammation and is inhibited by proline.

## Abstract

Radiation therapy often triggers inflammatory complications such as radiation colitis, which is driven by persistent M1 macrophage polarization. While metabolic reprogramming is pivotal in macrophage activation, the role of amino acid metabolism—particularly proline—in regulating radiation-induced inflammation remains unexplored. In this study, bone marrow-derived macrophages (BMDMs) and RAW264.7 cells exposed to 4 Gy radiation exhibited robust M1 polarization (increasing from 13.5% in controls to 23.7% in F4/80+CD86+ cells), elevated pro-inflammatory cytokines (TNF-α, IL-1β, IL-6; 3- to 6-fold increase), and mitochondrial dysfunction ( 30% decrease in ATP levels, 60% reduction in oxygen consumption rate [OCR], and 2-fold increase in mitochondrial ROS). Proline supplementation reversed these effects, suppressing M1 polarization by 50%, restoring ATP levels by 1.6-fold, and normalizing oxidative phosphorylation. Mechanistically, radiation upregulated ATPIF1 (1.8-fold increase) and phosphorylated mTOR (p-mTOR; 3.2-fold increase), while proline abolished these changes (ATPIF1 decreased by 30%, p-mTOR reduced by 50%). RNA-seq and metabolomics linked proline to ATP metabolism and amino acid homeostasis. ATPIF1 knockdown abolished radiation-induced pro-inflammatory effects and eliminated proline’s protective efficacy, confirming the ATPIF1-mTOR axis as the central regulatory mechanism. In a rat radiation colitis model, proline mitigated colon shortening, reduced histopathological damage, and decreased M1 macrophage infiltration. Collectively, our findings establish the ATPIF1-mTOR axis as a critical mediator of radiation-induced M1 macrophage polarization, which is effectively countered by proline supplementation.

The online version contains supplementary material available at 10.1007/s10753-025-02404-3.

## Linked entities

- **Genes:** ATP5IF1 (ATP synthase inhibitory factor subunit 1) [NCBI Gene 93974], MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475]
- **Chemicals:** proline (PubChem CID 614)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Atp5if1 (ATP synthase inhibitory factor subunit 1) [NCBI Gene 11983] {aka Atpi, Atpif1, IF(1), If1}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, Cd86 (CD86 antigen) [NCBI Gene 12524] {aka B7, B7-2, B7.2, B70, CLS1, Cd28l2}, Apc (APC, WNT signaling pathway regulator) [NCBI Gene 11789] {aka CC1, Min, mAPC}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56718] {aka Frap1, RAFT1}, Mrc1 (mannose receptor, C type 1) [NCBI Gene 17533] {aka CD206, MR}, Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, Kat6a (K(lysine) acetyltransferase 6A) [NCBI Gene 244349] {aka 1500036M03, 9930021N24Rik, MOZ, Myst3, Zfp220}, Fnip1 (folliculin interacting protein 1) [NCBI Gene 216742] {aka A730024A03Rik}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, MIR27B (microRNA 27b) [NCBI Gene 407019] {aka MIR-27b, MIRN27B, miRNA27B}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CD86 (CD86 molecule) [NCBI Gene 942] {aka B7-2, B7.2, B70, BU63, CD28LG2, CD86 v6}, Cort (cortistatin) [NCBI Gene 12854] {aka CST, PCST}, ATP5IF1 (ATP synthase inhibitory factor subunit 1) [NCBI Gene 93974] {aka ATPI, ATPIF1, ATPIP, IP}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, SP1 (Sp1 transcription factor) [NCBI Gene 6667], Cd86 (CD86 molecule) [NCBI Gene 56822] {aka B7-2}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, Park7 (Parkinson disease (autosomal recessive, early onset) 7) [NCBI Gene 57320] {aka DJ-1, Dj1}, Csf1 (colony stimulating factor 1 (macrophage)) [NCBI Gene 12977] {aka BAP025, Csfm, MCSF, Mhdabap25, PG-M-CSF, op}, MIR34A (microRNA 34a) [NCBI Gene 407040] {aka MIRN34A, miRNA34A, mir-34, mir-34a}, Cblif (cobalamin binding intrinsic factor) [NCBI Gene 29319] {aka Gif}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Prodh (proline dehydrogenase) [NCBI Gene 19125] {aka Pro-1, Pro1, Ym24d07}, Atp5if1 (ATP synthase inhibitory factor subunit 1) [NCBI Gene 25392] {aka Atpi, Atpif1, IF1PA}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, Lyst (lysosomal trafficking regulator) [NCBI Gene 17101] {aka D13Sfk13, beige, bg}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, Naa10 (N(alpha)-acetyltransferase 10, NatA catalytic subunit) [NCBI Gene 56292] {aka 2310039H09Rik, Ard1, Ard1a, Te2}, tor (tortured) [NCBI Gene 21977]
- **Diseases:** fibrosis (MESH:D005355), Inflammation (MESH:D007249), electron transport chain defects (MESH:D028361), cancer (MESH:D009369), atrophy (MESH:D001284), hyperemia (MESH:D006940), diarrhea (MESH:D003967), Damage (MESH:D020263), diarrheals (MESH:D004403), Colitis (MESH:D003092), ulceration (MESH:D014456), toxicity (MESH:D064420), lethargy (MESH:D053609), weight loss (MESH:D015431), Dehydration (MESH:D003681), necrosis (MESH:D009336), Radiation (MESH:D011832), tissue injury (MESH:D017695), colonic damage (MESH:D003108)
- **Chemicals:** Proline (MESH:D011392), oxygen (MESH:D010100), Lactate (MESH:D019344), streptomycin (MESH:D013307), metformin (MESH:D008687), MitoSOX Red (MESH:C000597839), CCK-8 (MESH:D012844), DCF-HDA (MESH:C029569), glutamate (MESH:D018698), SDS (MESH:D012967), FCCP (MESH:D002259), FITC-dextran (MESH:C015219), nitric oxide (MESH:D009569), H&amp;E (MESH:D006371), Dextran (MESH:D003911), DyLight 488 (-), penicillin (MESH:D010406), puromycin (MESH:D011691), alpha-ketoglutarate (MESH:D007656), amino acid (MESH:D000596), MHY1485 (MESH:C577756), fatty acid (MESH:D005227), arginine (MESH:D001120), glutamine (MESH:D005973), steroids (MESH:D013256), Rotenone (MESH:D012402), CO2 (MESH:D002245), ATP (MESH:D000255), Antimycin A (MESH:D000968), PVDF (MESH:C024865), PBS (MESH:D007854), ROS (MESH:D017382), oligomycin (MESH:D009840), DAPI (MESH:C007293), glucose (MESH:D005947)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** proline by the leucine, S0033S
- **Cell lines:** /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985), RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12960323/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12960323/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12960323/full.md

---
Source: https://tomesphere.com/paper/PMC12960323